Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 191INDUSTRY 31NETWORK 6OTHER_GOV 4NIH 3UNKNOWN 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 267Neoplasms 176Colorectal Neoplasms 133Stomach Neoplasms 107Uterine Cervical Neoplasms 95Carcinoma, Non-Small-Cell Lung 89Prostatic Neoplasms 82Lung Neoplasms 78Carcinoma, Hepatocellular 72Rectal Neoplasms 64Ovarian Neoplasms 54Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Recurrence 43Multiple Myeloma 39Neoplasm Metastasis 38Head and Neck Neoplasms 37Endometrial Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Motor Activity 34Melanoma 33Polycystic Ovary Syndrome 32Lymphoma 32Urinary Bladder Neoplasms 31Leukemia, Myeloid, Acute 30Thyroid Neoplasms 29Small Cell Lung Carcinoma 28Nasopharyngeal Carcinoma 25Lymphoma, Non-Hodgkin 25

Interventions

Tablets 1Standard of Care 1Serotonin 5-HT3 Receptor Antagonists 1Olanzapine 1Megestrol Acetate 1Megestrol 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Vomiting × Clear all
NCT03232541 2025-08-24

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

Västernorrland County Council, Sweden

Phase NA Completed
198 enrolled
BreastGastrointestinalGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Vomiting, Colorectal Neoplasms

NCT04232423 2022-01-21

OLN-EME

Department of Medical Services Ministry of Public Health of Thailand

Phase 3 Completed
90 enrolled

Vomiting

NCT03639415 2021-03-08

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Fujian Cancer Hospital

Phase 4 Withdrawn

Cancer Pain, Dizziness, Nausea, Pain, Intractable, Vomiting

NCT04430361 2020-06-12

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Henan Cancer Hospital

Phase 2 Unknown
120 enrolled

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡